Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Bitcoin Hyper News as BTC Fades and DeepSnitch AI Hits Final 100X Stretch

bitcoin38 main

The White House crypto council director recently called the idea of operating without market rules a “fantasy” as legislation stalls. This regulatory uncertainty creates a signal-to-noise problem for every retail trader trying to navigate the market.

But DeepSnitch AI lets traders navigate the back-and-forth of political negotiations. It has already raised over $1.29M from investors hunting for the next parabolic runner. With the token priced at only $0.03609 in Stage 4, the window to secure these initial levels is closing fast.

Here is why many think it is the best crypto to buy in 2026.

deepsnitch

White House advisor warns market rules are inevitable for long-term crypto survival

The Director of the crypto advisory council argues that the industry cannot function without clear guidelines. He suggests that choosing workable legislation now is better than risking harsher rules later. This debate arises while industry leaders argue over necessary compromises for the Clarity Act. 

The uncertainty creates policy risks that most traders are unprepared to handle, and DeepSnitch AI provides the intelligence layer needed to translate these bill changes into tradable scenarios. 

It allows you to see how lobbying headlines might impact your portfolio before the crowd reacts. You can monitor on-chain moves and lobbying headlines through a unified intelligence dashboard. 

DeepSnitch AI best crypto presale of 2026

By blending geopolitical event detection with on-chain patterns, DeepSnitch AI gives you the radar needed to act on demand spikes. This system levels the playing field by giving you the same surveillance tools used by market insiders. It transforms raw blockchain noise into clear signals for the 1 billion people using Telegram.

The platform uses five specialized AI agents to monitor the market 24/7. These include SnitchFeed, SnitchScan, SnitchGPT, SnitchCast, and the recently activated AuditSnitch. Four of these agents are already live for presale holders to test. This utility allows you to front-run institutional capital by tracking whale moves and sentiment flips.

AuditSnitch is the big practical change in the latest development update. It allows you to paste any contract address for an instant forensic verdict of CLEAN, CAUTION, or SKETCHY. 

This tool helps you avoid the instant rug landmines that plague every new cycle. SnitchFeed acts as your radar for Dominance Surges and sentiment flips on social media. And SnitchGPT simplifies on-chain chaos by answering queries in plain English directly inside Telegram. SnitchCast curates the latest news and alpha so you never miss a project launch.

The project has raised $1.29M and is moving through Stage 4 rapidly. The team has also teased a mystery game-changing announcement dropping in the coming days. This secret news is expected to be a major catalyst for the token price, which currently sits at $0.03609, but only for a limited time. 

Bitcoin Hyper ecosystem updates 

Bitcoin Hyper is gaining traction as a Layer 2 solution designed to fix slow transaction speeds. The project has raised about $30M to build an SVM-based architecture for fast smart contracts. But its upside potential remains limited compared to early-stage AI projects. 

Hyper development progress focuses on bridging liquidity while maintaining original security. But traders watching the Bitcoin Hyper news often favor AI analytics tools for navigating volatility. With a mainnet release still months away, investors are rotating into projects with live utility that can protect their capital immediately.

Bitcoin price analysis 

On January 21, Bitcoin was priced at around $87K after a sharp correction. This move triggered $708.9M in crypto liquidations over a 24-hour window. Most of these losses came from forced selling in long positions.

chart

Analysts suggest this leverage reset could reduce near-term pressure once the cascade slows. But the recovery remains choppy as investors digest the regulatory uncertainty. 

Bottom line

The push for market rules proves that the financial landscape is shifting toward data-driven security. DeepSnitch AI is the only project providing the real-time tools needed to survive these policy shocks. 

With $1.29M raised and the launch just 2 weeks away, the chance to buy at $0.03609 is vanishing. Use bonus code “DSNTVIP300” for a 300% bonus on $30K and above. Or use “DSNTVIP150” for 150% on $10K, “DSNTVIP50” for 50% on $5K, and “DSNTVIP30” for 30% on $2K. 

You must act now to secure your DSNT tokens before the January launch deadline ends this opportunity forever.

For more information, visit the official website, and follow X and Telegram.

deepsnitch

FAQ

How does Bitcoin Hyper news impact the market?

Regulatory shifts create volatility that DeepSnitch AI tracks in real-time, helping you spot market trends before the headlines.

Can DeepSnitch AI help me find the latest Bitcoin Hyper news and token news?

Yes, because the SnitchCast agent delivers breaking news and alpha directly to your Telegram or X account.

Is DeepSnitch AI a better investment than Bitcoin?

While Bitcoin offers stability, DeepSnitch AI provides much higher 100X potential and actionable intelligence for the average trader.

This article is not intended as financial advice. Educational purposes only.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26